Abeona Therapeutics (ABEO) Receivables - Other (2020 - 2025)
Abeona Therapeutics (ABEO) has 6 years of Receivables - Other data on record, last reported at $1.6 million in Q3 2025.
- For Q3 2025, Receivables - Other rose 1.0% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 1.0%, while the annual FY2024 figure was $1.6 million, 23.81% down from the prior year.
- Receivables - Other reached $1.6 million in Q3 2025 per ABEO's latest filing, down from $1.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $26.3 million in Q3 2022 and bottomed at $188000.0 in Q4 2022.
- Average Receivables - Other over 5 years is $3.3 million, with a median of $1.6 million recorded in 2025.
- Peak YoY movement for Receivables - Other: tumbled 93.73% in 2022, then soared 1200.0% in 2023.
- A 5-year view of Receivables - Other shows it stood at $3.0 million in 2021, then crashed by 93.73% to $188000.0 in 2022, then skyrocketed by 1200.0% to $2.4 million in 2023, then crashed by 34.53% to $1.6 million in 2024, then increased by 1.0% to $1.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $1.6 million in Q3 2025, $1.6 million in Q2 2025, and $1.6 million in Q1 2025.